MAIA Biotechnology, Inc
444 W Lake St Ste 1700
Chicago, IL 60606
MAIA Biotechnology, Inc., based in Chicago, IL, is focused on developing innovative cancer therapies through its pipeline of products currently under clinical investigation. The company's research emphasizes telomere targeting immunotherapies, including their lead program, Ateganosine, and several second-generation initiatives.
Committed to advancing cancer treatment, MAIA Biotechnology's efforts are grounded in a scientific approach, although the safety and effectiveness of its products have yet to be established. The company's dedicated management team and advisory board guide its mission to innovate within the oncology landscape.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
